American biopharmaceutical company, Pfizer has announced that COVID-19 vaccine would be ready for emergency use by September.
According to the pharmaceutical giant, it will begin testing of the experimental vaccine in the US next week.
This is happening a week after Germany approved its first human trial of a possible COVID-19 vaccine. The vaccine, named BNT162, was developed by Biontech, a Mainz-based company.
The company had said the vaccine would be tested in the US after the human trials in Germany.
The United Kingdom had also announced that there would be clinical trials of a potential COVID-19 vaccine.
The World Health Organisation (WHO) said there are about 20 different potential COVID-19 vaccines currently in development.
Some of the companies working on a vaccine said they are accelerating the timeline for testing as experts predict that the COVID-19 pandemic may last till 2021.
According to Worldometer, confirmed cases of COVID-19 globally have risen to 3,150,478, with 218,466 deaths. But 964,161 persons have recovered.
Share this post with your Friends on
Looking for something? Search below
You may be interested
Time to end government by palliatives – By Hassan Gimba
Webby - March 25, 2024This article is a repeat as it was first published on November 1, 2020. Palliative–this ten-letter word has taken over…
An Open letter to President Bola Ahmed Tinubu (GCFR) On How The Scourge Of INSURGENCY Can Be Scientifically Tackled In Nigeria
Webby - March 25, 2024Your Excellency sir,I am very hopeful and confident that this letter will get to your attention. I am writing you…
Social Media Influencer Ijele Arrested For Accusing Evang Ebuka Obi Of Fake Miracles
Webby - March 25, 2024A controversial Nigerian activist on social media, Mr. Chizorom Harrison Ofoegbu, popularly known as Ijele is being detained by the…